Daily as of 3 Nov 16:00 ET
- Price
- above both $36.39 vs 50 $29.53 / 200 $25.01
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 10 Jun 2026 · projected 12 bars out · tested 5 bars
PCRX | Pacira BioSciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$36.39
-$0.01 (-0.03%)
Pacira BioSciences (PCRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $36.39 vs 50 $24.83 / 200 $27.34
- Projection
- 🟨Golden cross projected in 10 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 6 Mar 2023 · projected 28 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $36.40 vs 50 $33.45 / 200 $27.12
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 21 Apr 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 10 Jun 2026 | 🟨Golden flat | daily | 12 bars out | 5 bar cross test |
| 21 Apr 2026 | 🟨Golden | 4-hour | 28 bars out | Not tested |
| 22 Jan 2026 | 💀Death | 4-hour | 27 bars out | Not tested |
| 16 Dec 2025 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 4 Nov 2025 | 💀Death moderate | daily | 21 bars out | 2 bar cross test |
About PCRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall